GO.cluster	IC	GO.ID	term	definition	Aboral_elim.genes_frequency	Aboral_elim.pvalue	Aboral_elim.-log10_pvalue	Aboral_elim.Significant_genes	Aboral_elim.Significant_genes_symbol
"1"	7.57	"GO:0008347"	"glial cell migration"	"The orderly movement of a glial cell, non-neuronal cells that provide support and nutrition, maintain homeostasis, form myelin, and participate in signal transmission in the nervous system."	"19.355% (6/31)"	0.0006293297	3.2	"Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g942.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12453.t2"	"Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Matrilin-2;Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Matrilin-2"
"1"	7.81	"GO:0042659"	"regulation of cell fate specification"	"Any process that mediates the adoption of a specific fate by a cell."	"19.231% (5/26)"	0.001859748	2.73	"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g3509.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g5006.t1b"	"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)"
"1"	7.22	"GO:0001709"	"cell fate determination"	"The cellular developmental process involved in cell fate commitment that occurs after cell fate specification,  in which a cell is irreversibly committed to a cellular developmental fate which is heritable on cell division."	"16.129% (5/31)"	0.00416113	2.38	"Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g11002.t4"	"Protein Wnt-7a;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]"
"1"	8.76	"GO:0021781"	"glial cell fate commitment"	"The process in which the developmental fate of a cell becomes restricted such that it will develop into a glial cell."	"33.333% (3/9)"	0.003084219	2.51	"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g942.t1;Pocillopora_acuta_HIv2___TS.g11002.t4"	"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]"
"1"	7.46	"GO:0045669"	"positive regulation of osteoblast differentiation"	"Any process that activates or increases the frequency, rate or extent of osteoblast differentiation."	"18.919% (7/37)"	0.0002573786	3.59	"Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g3780.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g23673.t1"	"Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Fibrillin-2 [Cleaved into: Placensin];Collagen triple helix repeat-containing protein 1;Protein kinase C-binding protein NELL1 (NEL-like protein 1);Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339);Signal peptide, CUB and EGF-like domain-containing protein 3"
"1"	8.67	"GO:1905207"	"regulation of cardiocyte differentiation"	NA	"27.273% (3/11)"	0.005749353	2.24	"Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4"	"Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]"
"1"	8.67	"GO:0010002"	"cardioblast differentiation"	"The process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating."	"27.273% (3/11)"	0.005749353	2.24	"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g29895.t1;Pocillopora_acuta_HIv2___TS.g11002.t4"	"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]"
"2"	8.36	"GO:0002052"	"positive regulation of neuroblast proliferation"	"Any process that activates or increases the rate of neuroblast proliferation."	"26.667% (4/15)"	0.001502552	2.82	"Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g5115.t2"	"Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)"
"2"	5.61	"GO:0050767"	"regulation of neurogenesis"	"Any process that modulates the frequency, rate or extent of neurogenesis, the generation of cells in the nervous system."	"11.364% (20/176)"	0.001778991	2.75	"Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27337.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g3832.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7509.t2;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g5115.t2"	"Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Protein Wnt-7a;Transcription factor HES-4 (Hairy and enhancer of split 4) (Protein hairy-2);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Roundabout homolog 2;Diencephalon/mesencephalon homeobox protein 1-B;Roundabout homolog 2;Roundabout homolog 1;Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal];Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)"
"2"	6.65	"GO:0050768"	"negative regulation of neurogenesis"	"Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the generation of cells within the nervous system."	"11.429% (8/70)"	0.003022736	2.52	"Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27337.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___TS.g11002.t4"	"Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Protein Wnt-7a;Transcription factor HES-4 (Hairy and enhancer of split 4) (Protein hairy-2);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]"
"2"	8.87	"GO:0021891"	"olfactory bulb interneuron development"	"The process whose specific outcome is the progression of an interneuron residing in the olfactory bulb, from its initial commitment, to the fully functional differentiated cell."	"37.5% (3/8)"	0.002110815	2.68	"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1"	"Roundabout homolog 2;Roundabout homolog 2;Roundabout homolog 1"
"2"	5.54	"GO:0007411"	"axon guidance"	"The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues."	"9.639% (16/166)"	0.0002369834	3.63	"Pocillopora_acuta_HIv2___RNAseq.g21418.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g942.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b"	"POU domain protein CF1A (Chorion factor 1A) (CF1-A) (Protein drifter) (Ventral veins lacking protein);Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Protein Wnt-8b;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Matrilin-2;Roundabout homolog 2;Roundabout homolog 2;Roundabout homolog 1;Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Matrilin-2;Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Protein Wnt-8b;Protein Wnt-8b;Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]"
"2"	8.87	"GO:0014012"	"peripheral nervous system axon regeneration"	"The regrowth of axons outside the central nervous system (outside the brain and spinal cord) following an axonal injury."	"33.333% (3/9)"	0.003084219	2.51	"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1"	"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)"
"2"	6.68	"GO:0050773"	"regulation of dendrite development"	"Any process that modulates the frequency, rate or extent of dendrite development."	"11.765% (8/68)"	0.002514647	2.6	"Pocillopora_acuta_HIv2___RNAseq.g10343.t1;Pocillopora_acuta_HIv2___RNAseq.g21418.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g9056.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g25584.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1"	"Protocadherin Fat 3 (FAT tumor suppressor homolog 3);POU domain protein CF1A (Chorion factor 1A) (CF1-A) (Protein drifter) (Ventral veins lacking protein);Roundabout homolog 1;CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)"
"3"	7.43	"GO:0007476"	"imaginal disc-derived wing morphogenesis"	"The process in which the anatomical structures of the imaginal disc-derived wing are generated and organized. The wing is an appendage modified for flying."	"17.391% (4/23)"	0.00780995	2.11	"Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g30706.t1"	"Tissue inhibitor of metalloproteinase;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]"
"3"	9.46	"GO:0060447"	"bud outgrowth involved in lung branching"	"The process in which a region of the lung epithelium initiates an outgrowth."	"60% (3/5)"	0.0004079179	3.39	"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1"	"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)"
"3"	9.46	"GO:0060745"	"mammary gland branching involved in pregnancy"	"The process in which the branching structure of the mammary gland duct is generated and organized as a part of pregnancy."	"60% (3/5)"	0.0004079179	3.39	"Pocillopora_acuta_HIv2___RNAseq.g21562.t1;Pocillopora_acuta_HIv2___RNAseq.g9085.t1;Pocillopora_acuta_HIv2___TS.g23391.t1"	"CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)"
"3"	7.77	"GO:0030707"	"follicle cell of egg chamber development"	"The process that occurs during oogenesis involving the ovarian follicle cells, somatic cells which surround the germ cells of an ovary. An example of this is found in Drosophila melanogaster."	"23.077% (3/13)"	0.009459176	2.02	"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g6576.t2"	"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];LIM domain-containing protein jub"
"3"	9.12	"GO:0048808"	"male genitalia morphogenesis"	"The process in which the anatomical structures of male genitalia are generated and organized."	"42.857% (3/7)"	0.0013544	2.87	"Pocillopora_acuta_HIv2___RNAseq.g2037.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4"	"Kelch-like protein 10;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]"
"3"	9.27	"GO:0035846"	"oviduct epithelium development"	"The progression of the oviduct epithelium over time from its initial formation to the mature structure. An oviduct is a tube through which an ova passes from the ovary to the uterus, or from the ovary to the outside of the organism. The oviduct epithelium is the specialized epithelium that lines the oviduct."	"66.667% (4/6)"	2.124101e-05	4.67	"Pocillopora_acuta_HIv2___RNAseq.g21562.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g9085.t1;Pocillopora_acuta_HIv2___TS.g23391.t1"	"CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)"
"3"	8.29	"GO:0060740"	"prostate gland epithelium morphogenesis"	"The process in which the anatomical structures of epithelia of the prostate gland are generated and organized. An epithelium consists of closely packed cells arranged in one or more layers, that covers the outer surfaces of the body or lines any internal cavity or tube."	"25% (3/12)"	0.007468328	2.13	"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1"	"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)"
"3"	9.46	"GO:0060739"	"mesenchymal-epithelial cell signaling involved in prostate gland development"	"Any process that mediates the transfer of information from a mesenchymal cell to an epithelial cell where it is received and interpreted contributing to the progression of the prostate gland over time."	"60% (3/5)"	0.0004079179	3.39	"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1"	"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)"
"4"	7.98	"GO:1902742"	"apoptotic process involved in development"	NA	"23.529% (4/17)"	0.002478132	2.61	"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1"	"Roundabout homolog 2;Roundabout homolog 2;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5)"
"4"	8.29	"GO:0048859"	"formation of anatomical boundary"	"The process in which the limits of an anatomical structure are generated. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome."	"25% (3/12)"	0.007468328	2.13	"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g30706.t1"	"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]"
"4"	9.46	"GO:0060061"	"Spemann organizer formation"	"Formation of the specialized region on the dorsalmost side of the embryo that acts as the main signaling center establishing the vertebrate body plan."	"60% (3/5)"	0.0004079179	3.39	"Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1"	"Protein Wnt-8a;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5)"
"4"	6.17	"GO:0031099"	"regeneration"	"The regrowth of a lost or destroyed body part, such as an organ or tissue. This process may occur via renewal, repair, and/or growth alone (i.e. increase in size or mass)."	"13.559% (16/118)"	0.002898498	2.54	"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g9381.t1;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b"	"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Protein Wnt-7a;Protein Wnt-8b;Matrilin-2;Protein jagged-1 (Jagged1) (CD antigen CD339);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Matrilin-2;Protein Wnt-8b;Protein Wnt-8b;Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)"
"4"	4.25	"GO:0048729"	"tissue morphogenesis"	"The process in which the anatomical structures of a tissue are generated and organized."	"8.802% (36/409)"	0.002368344	2.63	"Pocillopora_acuta_HIv2___RNAseq.7335_t;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g21562.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g26270.t1a;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g29895.t1;Pocillopora_acuta_HIv2___RNAseq.g3088.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g9085.t1;Pocillopora_acuta_HIv2___RNAseq.g942.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12304.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g23391.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g568.t1;Pocillopora_acuta_HIv2___TS.g7543.t1"	"Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1);Collagen triple helix repeat-containing protein 1;Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1);Protein Wnt-7a;Protein Wnt-8b;Protein Wnt-8a;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Roundabout homolog 2;Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND);Nephrocystin-3;Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Protein Wnt-8b;Protein Wnt-8b;CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A);SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)"
"4"	8.02	"GO:0036342"	"post-anal tail morphogenesis"	"The process in which a post-anal tail is generated and organized. A post-anal tail is a muscular region of the body that extends posterior to the anus. The post-anal tail may aid locomotion and balance."	"19.048% (4/21)"	0.005578177	2.25	"Pocillopora_acuta_HIv2___RNAseq.22092_t;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b"	"Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);Protein Wnt-8a;Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)"
"5"	8.67	"GO:0072070"	"loop of Henle development"	"The process whose specific outcome is the progression of the loop of Henle over time, from its formation to the mature structure. The loop of Henle is a nephron tubule that connects the proximal convoluted tubule to the distal convoluted tubule."	"30% (3/10)"	0.004292115	2.37	"Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1"	"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339)"
"5"	7.13	"GO:0001656"	"metanephros development"	"The process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. In mammals, the metanephros is the excretory organ of the fetus, which develops into the mature kidney and is formed from the rear portion of the nephrogenic cord. The metanephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine."	"17.647% (6/34)"	0.001051954	2.98	"Pocillopora_acuta_HIv2___RNAseq.g20144.t1;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___TS.g23602.t1"	"Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Roundabout homolog 2;Roundabout homolog 2;Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)"
"5"	7.48	"GO:0035904"	"aorta development"	"The progression of the aorta over time, from its initial formation to the mature structure. An aorta is an artery that carries blood from the heart to other parts of the body."	"16.667% (6/36)"	0.001436167	2.84	"Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1"	"Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Roundabout homolog 2;Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339)"
"5"	7.1	"GO:0030282"	"bone mineralization"	"The deposition of hydroxyapatite, a form of calcium phosphate with the formula Ca10(PO4)6(OH)2, in bone tissue."	"18% (9/50)"	5.141462e-05	4.29	"Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g3780.t1;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g5338.t1"	"Fibrillin-2 [Cleaved into: Placensin];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Protein kinase C-binding protein NELL1 (NEL-like protein 1);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-1(XXVII) chain B;Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)"
"5"	7.46	"GO:0003197"	"endocardial cushion development"	"The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves."	"17.241% (5/29)"	0.003080034	2.51	"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1"	"Roundabout homolog 2;Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339)"
"5"	8.87	"GO:0021854"	"hypothalamus development"	"The progression of the hypothalamus region of the forebrain, from its initial formation to its mature state."	"33.333% (3/9)"	0.003084219	2.51	"Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1"	"Protein Wnt-8b;Protein Wnt-8b;Protein Wnt-8b"
"5"	6.06	"GO:0051216"	"cartilage development"	"The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate."	"11% (11/100)"	0.0007401242	3.13	"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.22092_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.g13857.t1;Pocillopora_acuta_HIv2___RNAseq.g15163.t1;Pocillopora_acuta_HIv2___RNAseq.g20144.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g5338.t1"	"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Bone morphogenetic protein 2 (BMP-2);Noggin-2;Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Protein Wnt-7a;Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)"
"5"	5.06	"GO:0001501"	"skeletal system development"	"The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton)."	"11.25% (27/240)"	2.320907e-05	4.63	"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.22092_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.g10385.t1;Pocillopora_acuta_HIv2___RNAseq.g13857.t1;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g15163.t1;Pocillopora_acuta_HIv2___RNAseq.g19284.t1;Pocillopora_acuta_HIv2___RNAseq.g20144.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g29895.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g30131.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g5115.t2;Pocillopora_acuta_HIv2___TS.g5338.t1"	"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);Bone morphogenetic protein 2 (BMP-2);Fibrillin-2 [Cleaved into: Placensin];Noggin-2;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Protein Wnt-7a;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-1(XXVII) chain B;Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)"
"5"	4.95	"GO:0048880"	"sensory system development"	"The process whose specific outcome is the progression of a sensory system over time from its formation to the mature structure."	"8.647% (23/266)"	0.006967671	2.16	"Pocillopora_acuta_HIv2___RNAseq.g10343.t1;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g27337.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g3832.t1;Pocillopora_acuta_HIv2___RNAseq.g434.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g9588.t1;Pocillopora_acuta_HIv2___RNAseq.g9589.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b"	"Protocadherin Fat 3 (FAT tumor suppressor homolog 3);Fibrillin-2 [Cleaved into: Placensin];Protein Wnt-8b;Protein Wnt-8a;Transcription factor HES-4 (Hairy and enhancer of split 4) (Protein hairy-2);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Diencephalon/mesencephalon homeobox protein 1-B;Frizzled-5 (Fz-5) (Xfz5);Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Protein jagged-1 (Jagged1) (CD antigen CD339);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Homeobox protein otx5-B (Orthodenticle homolog 5-B) (XOtx5b);Homeobox protein OTX1 B (zOtx1) (Orthodenticle homolog 1 B);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Protein Wnt-8b;Protein Wnt-8b;Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)"
"6"	8.18	"GO:0003180"	"aortic valve morphogenesis"	"The process in which the structure of the aortic valve is generated and organized."	"22.222% (4/18)"	0.003098964	2.51	"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1"	"Roundabout homolog 2;Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Roundabout homolog 1"
"6"	8.23	"GO:0003184"	"pulmonary valve morphogenesis"	"The process in which the structure of the pulmonary valve is generated and organized."	"29.412% (5/17)"	0.0002269239	3.64	"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1"	"Roundabout homolog 2;Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339)"
"7"	7.46	"GO:0042475"	"odontogenesis of dentin-containing tooth"	"The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel."	"15.152% (5/33)"	0.005488912	2.26	"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1"	"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)"
"7"	3.76	"GO:0009887"	"animal organ morphogenesis"	"Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions."	"9.076% (56/617)"	0.001895795	2.72	"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.22092_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.g10343.t1;Pocillopora_acuta_HIv2___RNAseq.g10385.t1;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g19284.t1;Pocillopora_acuta_HIv2___RNAseq.g2037.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g21562.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g26270.t1a;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27337.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g29895.t1;Pocillopora_acuta_HIv2___RNAseq.g3088.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9085.t1;Pocillopora_acuta_HIv2___RNAseq.g9588.t1;Pocillopora_acuta_HIv2___RNAseq.g9589.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g23391.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g3883.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g5338.t1;Pocillopora_acuta_HIv2___TS.g568.t1"	"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Protocadherin Fat 3 (FAT tumor suppressor homolog 3);Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);Tissue inhibitor of metalloproteinase;Fibrillin-2 [Cleaved into: Placensin];Collagen triple helix repeat-containing protein 1;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Kelch-like protein 10;Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1);Protein Wnt-7a;Protein Wnt-8b;Transcription factor HES-4 (Hairy and enhancer of split 4) (Protein hairy-2);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Roundabout homolog 2;Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND);Nephrocystin-3;Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Homeobox protein otx5-B (Orthodenticle homolog 5-B) (XOtx5b);Homeobox protein OTX1 B (zOtx1) (Orthodenticle homolog 1 B);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Protein Wnt-8b;Protein Wnt-8b;Collagen alpha-1(XXVII) chain B;CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Cysteine-rich protein 1 (CRP-1) (Cysteine-rich heart protein) (CRHP) (hCRHP) (Cysteine-rich intestinal protein) (CRIP);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)"
"7"	8.5	"GO:0043589"	"skin morphogenesis"	"The process in which the anatomical structures of the skin are generated and organized. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner, sensitive and vascular dermis (cutis, corium or true skin) composed mostly of connective tissue."	"53.846% (7/13)"	8.888655e-08	7.05	"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b"	"Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)"
"8"	4.43	"GO:0048598"	"embryonic morphogenesis"	"The process in which anatomical structures are generated and organized during the embryonic phase. The embryonic phase begins with zygote formation. The end of the embryonic phase is organism-specific. For example, it would be at birth for mammals, larval hatching for insects and seed dormancy in plants."	"7.772% (30/386)"	0.00255576	2.59	"Pocillopora_acuta_HIv2___RNAseq.22092_t;Pocillopora_acuta_HIv2___RNAseq.7335_t;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g19284.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g29895.t1;Pocillopora_acuta_HIv2___RNAseq.g3088.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g5896.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g942.t1;Pocillopora_acuta_HIv2___RNAseq.g9589.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g568.t1"	"Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1);Fibrillin-2 [Cleaved into: Placensin];Collagen triple helix repeat-containing protein 1;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Protein Wnt-7a;Protein Wnt-8b;Protein Wnt-8a;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND);Nephrocystin-3;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Probable N-acetyltransferase camello (EC 2.3.1.-) (Xcml);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A);Homeobox protein OTX1 B (zOtx1) (Orthodenticle homolog 1 B);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Protein Wnt-8b;Protein Wnt-8b;Collagen alpha-1(XXVII) chain B;Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)"
"8"	9.46	"GO:0071699"	"olfactory placode morphogenesis"	"The process in which the anatomical structures of the olfactory placode are generated and organized. The olfactory placode is a thickening of the neural ectoderm in the head region of the vertebrate embryo which develops into the olfactory region of the nasal cavity."	"60% (3/5)"	0.0004079179	3.39	"Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b"	"Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)"
"8"	8.87	"GO:0042067"	"establishment of ommatidial planar polarity"	"The specification of polarized ommatidia. Ommatidia occur in two chiral forms. The trapezoidal arrangement of photoreceptors in the dorsal part of the eye is the mirror image of that in the ventral part."	"42.857% (3/7)"	0.0013544	2.87	"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g30706.t1"	"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]"
"8"	9.46	"GO:0060898"	"eye field cell fate commitment involved in camera-type eye formation"	"The commitment of neurectodermal cells to cells of the eye field and their capacity to differentiate into eye field cells. Eye field cells are neurectodermal cells that will form the optic placode."	"60% (3/5)"	0.0004079179	3.39	"Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1"	"Protein Wnt-8b;Protein Wnt-8b;Protein Wnt-8b"
"8"	9.12	"GO:0043049"	"otic placode formation"	"The initial developmental process that will lead to the formation of the vertebrate inner ear. The otic placode forms as a thickening of the head ectoderm adjacent to the developing hindbrain."	"42.857% (3/7)"	0.0013544	2.87	"Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1"	"Protein Wnt-8b;Protein Wnt-8b;Protein Wnt-8b"
"9"	8.36	"GO:0007447"	"imaginal disc pattern formation"	"The regionalization process that results in defined areas of the imaginal disc that will undergo specific cell differentaiton. Imaginal discs are epithelial infoldings in the larvae of holometabolous insects that develop into adult appendages (legs, antennae, wings, etc.) during metamorphosis from larval to adult form."	"27.273% (3/11)"	0.005749353	2.24	"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g30706.t1"	"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]"
"9"	6.91	"GO:0009880"	"embryonic pattern specification"	"The process that results in the patterns of cell differentiation that will arise in an embryo."	"12.963% (7/54)"	0.002656459	2.58	"Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1"	"Protein Wnt-7a;Protein Wnt-8b;Protein Wnt-8a;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Protein Wnt-8b;Protein Wnt-8b"
"9"	6.43	"GO:0009953"	"dorsal/ventral pattern formation"	"The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism."	"15% (12/80)"	2.040867e-05	4.69	"Pocillopora_acuta_HIv2___RNAseq.g15163.t1;Pocillopora_acuta_HIv2___RNAseq.g22527.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g5138.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g568.t1"	"Noggin-2;Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid);Protein Wnt-7a;Protein Wnt-8a;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Iroquois-class homeodomain protein irx-4-A (Iroquois homeobox protein 4-A);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)"
"9"	8.5	"GO:0009954"	"proximal/distal pattern formation"	"The regionalization process in which specific areas of cell differentiation are determined along a proximal/distal axis. The proximal/distal axis is defined by a line that runs from main body (proximal end) of an organism outward (distal end)."	"25% (3/12)"	0.007468328	2.13	"Pocillopora_acuta_HIv2___RNAseq.g5138.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1"	"Iroquois-class homeodomain protein irx-4-A (Iroquois homeobox protein 4-A);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)"
"9"	9.46	"GO:0003129"	"heart induction"	"The close range interaction between mesoderm and endoderm or ectoderm that causes cells to change their fates and specify the development of the heart."	"60% (3/5)"	0.0004079179	3.39	"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1"	"Roundabout homolog 2;Roundabout homolog 2;Roundabout homolog 1"
"9"	8.76	"GO:0033339"	"pectoral fin development"	"The process whose specific outcome is the progression of the pectoral fin over time, from its formation to the mature structure."	"30% (3/10)"	0.004292115	2.37	"Pocillopora_acuta_HIv2___RNAseq.g29895.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b"	"Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)"
"9"	7.51	"GO:0002164"	"larval development"	"The process whose specific outcome is the progression of the larva over time, from its formation to the mature structure. The larva is the early, immature form of an that at birth or hatching is fundamentally unlike its parent and must metamorphose before assuming the adult characters."	"23.077% (6/26)"	0.0002282347	3.64	"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28575.t1a;Pocillopora_acuta_HIv2___RNAseq.g28577.t1;Pocillopora_acuta_HIv2___RNAseq.g3509.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g30706.t1"	"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]"
"9"	9.46	"GO:0048582"	"positive regulation of post-embryonic development"	"Any process that activates or increases the frequency, rate or extent of post-embryonic development. Post-embryonic development is defined as the process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure."	"60% (3/5)"	0.0004079179	3.39	"Pocillopora_acuta_HIv2___RNAseq.g2110.t1;Pocillopora_acuta_HIv2___RNAseq.g28575.t1a;Pocillopora_acuta_HIv2___RNAseq.g28577.t1"	"Arginine-specific demethylase JMJ22 (EC 1.14.11.-) (Arginine-specific histone demethylase JMJ22) (F-box protein JMJ22) (Jumonji domain-containing protein 22) (AtJMJ22) (Protein JUMONJI 22) ([histone H4]-dimethyl-L-arginine(3) monodemethylase JMJ22);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)"
"10"	4.15	"GO:0007155"	"cell adhesion"	"The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules."	"10.574% (70/662)"	0.000182103	3.74	"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.6832_t;Pocillopora_acuta_HIv2___RNAseq.g10343.t1;Pocillopora_acuta_HIv2___RNAseq.g10385.t1;Pocillopora_acuta_HIv2___RNAseq.g1119.t1;Pocillopora_acuta_HIv2___RNAseq.g11876.t1;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g13823.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14347.t1;Pocillopora_acuta_HIv2___RNAseq.g14373.t1;Pocillopora_acuta_HIv2___RNAseq.g14375.t1;Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g18385.t1;Pocillopora_acuta_HIv2___RNAseq.g19085.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g25351.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g25761.t1;Pocillopora_acuta_HIv2___RNAseq.g27031.t1;Pocillopora_acuta_HIv2___RNAseq.g28109.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28502.t1;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g29795.t1;Pocillopora_acuta_HIv2___RNAseq.g3826.t1;Pocillopora_acuta_HIv2___RNAseq.g3939.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g5896.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g805.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g9049.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g10825.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12860.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g24030.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g5115.t2;Pocillopora_acuta_HIv2___TS.g5308.t2;Pocillopora_acuta_HIv2___TS.g8258.t1;Pocillopora_acuta_HIv2___TS.g8259.t1b"	"Hemicentin-1 (Fibulin-6) (FIBL-6);Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B);Protocadherin Fat 3 (FAT tumor suppressor homolog 3);Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);Collagen alpha-6(VI) chain;Mucin-like protein;Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Tissue inhibitor of metalloproteinase;Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Mucin-like protein;Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-4(VI) chain;Collagen alpha-1(VI) chain;Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);BAG family molecular chaperone regulator 4 (BAG-4) (Bcl-2-associated athanogene 4) (Silencer of death domains);Halomucin;Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Hemicentin-2;Hemicentin-2;Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Mammalian ependymin-related protein 1 (MERP-1);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Collagen alpha-6(VI) chain;Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2);Fibulin-2 (FIBL-2);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Mucin-like protein;Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Roundabout homolog 2;Zonadhesin;Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2);Spondin-1 (F-spondin);Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Hemicentin-1 (Fibulin-6) (FIBL-6);Probable N-acetyltransferase camello (EC 2.3.1.-) (Xcml);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339);Protein turtle homolog B (Immunoglobulin superfamily member 9B);Hemicentin-1 (Fibulin-6) (FIBL-6);Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Collagen alpha-1(VI) chain;Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Hemicentin-1 (Fibulin-6) (FIBL-6);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12);Hemicentin-2;Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Hemicentin-2;Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)"
"10"	8.23	"GO:0016339"	"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules"	"The attachment of one cell to another cell via adhesion molecules that require the presence of calcium for the interaction."	"29.412% (5/17)"	0.0002269239	3.64	"Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g5308.t2"	"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)"
"10"	6.33	"GO:0007156"	"homophilic cell adhesion via plasma membrane adhesion molecules"	"The attachment of a plasma membrane adhesion molecule in one cell to an identical molecule in an adjacent cell."	"20.175% (23/114)"	6.698219e-12	11.17	"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g10343.t1;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___RNAseq.g19085.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g805.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g5308.t2;Pocillopora_acuta_HIv2___TS.g8258.t1;Pocillopora_acuta_HIv2___TS.g8259.t1b"	"Hemicentin-1 (Fibulin-6) (FIBL-6);Protocadherin Fat 3 (FAT tumor suppressor homolog 3);Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Hemicentin-1 (Fibulin-6) (FIBL-6);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Halomucin;Hemicentin-2;Hemicentin-2;Roundabout homolog 2;Roundabout homolog 2;Hemicentin-1 (Fibulin-6) (FIBL-6);Roundabout homolog 1;Protein turtle homolog B (Immunoglobulin superfamily member 9B);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Hemicentin-2;Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Hemicentin-2;Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)"
"10"	7.4	"GO:0007157"	"heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules"	"The attachment of an adhesion molecule in one cell to a nonidentical adhesion molecule in an adjacent cell."	"30.769% (12/39)"	4.846402e-09	8.31	"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1"	"Hemicentin-1 (Fibulin-6) (FIBL-6);Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Hemicentin-1 (Fibulin-6) (FIBL-6);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Hemicentin-1 (Fibulin-6) (FIBL-6);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)"
"11"	8.5	"GO:1901016"	"regulation of potassium ion transmembrane transporter activity"	NA	"23.077% (3/13)"	0.009459176	2.02	"Pocillopora_acuta_HIv2___RNAseq.g16285.t1;Pocillopora_acuta_HIv2___RNAseq.g23588.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b"	"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]"
"11"	8.76	"GO:0019755"	"one-carbon compound transport"	"The directed movement of one-carbon compounds into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore."	"30% (3/10)"	0.004292115	2.37	"Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___TS.g12304.t1;Pocillopora_acuta_HIv2___TS.g19887.t1"	"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69);Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase)"
"11"	7.6	"GO:0006826"	"iron ion transport"	"The directed movement of iron (Fe) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore."	"17.857% (5/28)"	0.002623269	2.58	"Pocillopora_acuta_HIv2___RNAseq.g14366.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g4878.t1;Pocillopora_acuta_HIv2___TS.g12848.t1"	"Scavenger receptor class A member 5;Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228);Scavenger receptor class A member 5"
"12"	8.58	"GO:0099545"	"trans-synaptic signaling by trans-synaptic complex"	"Cell-cell signaling between presynapse and postsynapse mediated by a trans-synaptic protein complex."	"25% (3/12)"	0.007468328	2.13	"Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1"	"Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)"
"12"	7.73	"GO:0045747"	"positive regulation of Notch signaling pathway"	"Any process that activates or increases the frequency, rate or extent of the Notch signaling pathway."	"21.429% (6/28)"	0.0003519511	3.45	"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g3509.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1"	"Roundabout homolog 2;E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26);Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339)"
"12"	5.77	"GO:0060070"	"canonical Wnt signaling pathway"	"The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes."	"9.249% (16/173)"	0.0003790036	3.42	"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.g17416.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g21032.t1;Pocillopora_acuta_HIv2___RNAseq.g2565.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g3088.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1"	"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Glypican-5 [Cleaved into: Secreted glypican-5];Collagen triple helix repeat-containing protein 1;Protein naked cuticle homolog 2-like (Naked-2-like) (Protein naked cuticle homolog 2-B) (Naked-2B);Secreted frizzled-related protein 5 (sFRP-5);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Protein Wnt-7a;Protein Wnt-8b;Protein Wnt-8a;Nephrocystin-3;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Protein Wnt-8b;Protein Wnt-8b"
"12"	6.38	"GO:0007162"	"negative regulation of cell adhesion"	"Any process that stops, prevents, or reduces the frequency, rate or extent of cell adhesion."	"11.957% (11/92)"	0.0003605228	3.44	"Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g5896.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g11002.t4"	"Tissue inhibitor of metalloproteinase;Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Probable N-acetyltransferase camello (EC 2.3.1.-) (Xcml);Protein jagged-1 (Jagged1) (CD antigen CD339);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]"
"12"	6.53	"GO:0010810"	"regulation of cell-substrate adhesion"	"Any process that modulates the frequency, rate or extent of cell-substrate adhesion. Cell-substrate adhesion is the attachment of a cell to the underlying substrate via adhesion molecules."	"9.639% (8/83)"	0.008531824	2.07	"Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g28109.t1;Pocillopora_acuta_HIv2___RNAseq.g3826.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1"	"Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Fibulin-2 (FIBL-2);Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2);Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339)"
"12"	3.78	"GO:0042127"	"regulation of cell population proliferation"	"Any process that modulates the frequency, rate or extent of cell proliferation."	"6.134% (56/913)"	0.002131186	2.67	"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.22092_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.g10343.t1;Pocillopora_acuta_HIv2___RNAseq.g10385.t1;Pocillopora_acuta_HIv2___RNAseq.g10557.t1;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g14750.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g18763.t1;Pocillopora_acuta_HIv2___RNAseq.g21418.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g25184.t1;Pocillopora_acuta_HIv2___RNAseq.g25186.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g26604.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g3509.t1;Pocillopora_acuta_HIv2___RNAseq.g3780.t1;Pocillopora_acuta_HIv2___RNAseq.g434.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9049.t1;Pocillopora_acuta_HIv2___RNAseq.g9056.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.7324_t;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g13017.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g25584.t1;Pocillopora_acuta_HIv2___TS.g28528.t1b;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g5115.t2;Pocillopora_acuta_HIv2___TS.g568.t1"	"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Protocadherin Fat 3 (FAT tumor suppressor homolog 3);Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);Fibroblast growth factor receptor-like 1;Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Novel Sp1-like zinc finger transcription factor 1) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3) (Transcription factor NSLP1);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Collagen triple helix repeat-containing protein 1;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);POU domain protein CF1A (Chorion factor 1A) (CF1-A) (Protein drifter) (Ventral veins lacking protein);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);TNF receptor-associated factor 5;TNF receptor-associated factor 5;Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1);Protein Wnt-7a;Protein Wnt-8a;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Roundabout homolog 2;E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26);Protein kinase C-binding protein NELL1 (NEL-like protein 1);Frizzled-5 (Fz-5) (Xfz5);Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Roundabout homolog 1;Protein jagged-1 (Jagged1) (CD antigen CD339);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1);CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Homeobox protein koza (Homeodomain transcription factor koza);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Aryl hydrocarbon receptor (Ah receptor) (AhR);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Tyrosine kinase receptor CEK2);Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)"
"12"	8.58	"GO:0035988"	"chondrocyte proliferation"	"The multiplication or reproduction of chondrocytes by cell division, resulting in the expansion of their population. A chondrocyte is a polymorphic cell that forms cartilage."	"25% (3/12)"	0.007468328	2.13	"Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.g19284.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1"	"Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP)"
"13"	8.5	"GO:1904395"	"positive regulation of skeletal muscle acetylcholine-gated channel clustering"	NA	"23.077% (3/13)"	0.009459176	2.02	"Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b"	"Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]"
"13"	8.99	"GO:0036309"	"protein localization to M-band"	"Any process in which a protein is transported to, and/or maintained in, the M band. The M band is the midline of aligned thick filaments in a sarcomere."	"37.5% (3/8)"	0.002110815	2.68	"Pocillopora_acuta_HIv2___RNAseq.g16285.t1;Pocillopora_acuta_HIv2___RNAseq.g23588.t1;Pocillopora_acuta_HIv2___TS.g15585.t1"	"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)"
"13"	7.98	"GO:0045792"	"negative regulation of cell size"	"Any process that reduces cell size."	"18.182% (4/22)"	0.006632092	2.18	"Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___TS.g5308.t2"	"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)"
"13"	4.74	"GO:0050808"	"synapse organization"	"A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell)."	"10.127% (32/316)"	0.001926626	2.72	"Pocillopora_acuta_HIv2___RNAseq.673_t;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g28252.t1;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g7219.t1;Pocillopora_acuta_HIv2___RNAseq.g805.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g29912.t2;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g8131.t1;Pocillopora_acuta_HIv2___TS.g8258.t1;Pocillopora_acuta_HIv2___TS.g8259.t1b"	"LHFPL tetraspan subfamily member 4 protein (Lipoma HMGIC fusion partner-like 4 protein);Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Hemicentin-2;Hemicentin-2;Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Protein Wnt-7a;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Roundabout homolog 2;Roundabout homolog 2;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Roundabout homolog 1;Cortactin-binding protein 2 (CortBP2);Protein turtle homolog B (Immunoglobulin superfamily member 9B);Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Hemicentin-2;E3 ubiquitin-protein ligase PDZRN3-B (EC 2.3.2.27) (PDZ domain-containing RING finger protein 3-B);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158);Hemicentin-2;Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)"
"13"	7.85	"GO:0099560"	"synaptic membrane adhesion"	"The attachment of presynaptic membrane to postsynaptic membrane via adhesion molecules that are at least partially embedded in the plasma membrane."	"29.167% (7/24)"	1.282561e-05	4.89	"Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g805.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g8259.t1b"	"Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Protein turtle homolog B (Immunoglobulin superfamily member 9B);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)"
"13"	9.12	"GO:0070208"	"protein heterotrimerization"	"The formation of a protein heterotrimer, a macromolecular structure consisting of three noncovalently associated subunits, of which not all are identical."	"71.429% (5/7)"	1.030564e-06	5.99	"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1"	"Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen)"
"13"	8.67	"GO:0044036"	"cell wall macromolecule metabolic process"	"The chemical reactions and pathways involving macromolecules forming, or destined to form, part of the cell wall. A cell wall is a rigid or semi-rigid envelope lying outside the cell membrane of plant, fungal and most prokaryotic cells, maintaining their shape and protecting them from osmotic lysis."	"37.5% (3/8)"	0.002110815	2.68	"Pocillopora_acuta_HIv2___RNAseq.g20718.t1;Pocillopora_acuta_HIv2___RNAseq.g28575.t1a;Pocillopora_acuta_HIv2___RNAseq.g28577.t1"	"Probable glycosyltransferase STELLO2 (EC 2.4.-.-);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)"
"13"	8.43	"GO:0042546"	"cell wall biogenesis"	"A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a cell wall. Includes biosynthesis of constituent macromolecules, such as proteins and polysaccharides, and those macromolecular modifications that are involved in synthesis or assembly of the cellular component. A cell wall is the rigid or semi-rigid envelope lying outside the cell membrane of plant, fungal and most prokaryotic cells, maintaining their shape and protecting them from osmotic lysis."	"30% (3/10)"	0.004292115	2.37	"Pocillopora_acuta_HIv2___RNAseq.g20718.t1;Pocillopora_acuta_HIv2___RNAseq.g28575.t1a;Pocillopora_acuta_HIv2___RNAseq.g28577.t1"	"Probable glycosyltransferase STELLO2 (EC 2.4.-.-);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)"
"14"	7.54	"GO:0085029"	"extracellular matrix assembly"	"The aggregation, arrangement and bonding together of the extracellular matrix."	"18.75% (6/32)"	0.0007519746	3.12	"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15832.t1"	"Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Collagen alpha-2(I) chain (Alpha-2 type I collagen)"
"14"	5.35	"GO:0045229"	"external encapsulating structure organization"	"A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of external structures that lie outside the plasma membrane and surround the entire cell."	"16.972% (37/218)"	0.001106654	2.96	"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14347.t1;Pocillopora_acuta_HIv2___RNAseq.g16526.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g19284.t1;Pocillopora_acuta_HIv2___RNAseq.g20718.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24766.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28504.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g3826.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g1340.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g24066.t1;Pocillopora_acuta_HIv2___TS.g5338.t1"	"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Hemicentin-1 (Fibulin-6) (FIBL-6);SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Tissue inhibitor of metalloproteinase;Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-4(VI) chain;Cell wall protein DAN4 (Delayed anaerobic protein 4);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Probable glycosyltransferase STELLO2 (EC 2.4.-.-);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Papilin;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Matrilin-4 (MAT-4);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Matrilin-2;Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Matrilin-2;Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Collagen alpha-1(XXVII) chain B;Collagen alpha-2(IV) chain;Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)"
"14"	7.22	"GO:0030199"	"collagen fibril organization"	"Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix."	"13.953% (6/43)"	0.003658225	2.44	"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15832.t1"	"Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Collagen alpha-2(I) chain (Alpha-2 type I collagen)"
"14"	5.42	"GO:0030198"	"extracellular matrix organization"	"A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix."	"16.256% (33/203)"	4.584308e-09	8.34	"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14347.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g19284.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24766.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28504.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g3826.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g1340.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g24066.t1;Pocillopora_acuta_HIv2___TS.g5338.t1"	"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Hemicentin-1 (Fibulin-6) (FIBL-6);SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Tissue inhibitor of metalloproteinase;Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-4(VI) chain;Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Papilin;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Matrilin-4 (MAT-4);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Matrilin-2;Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Matrilin-2;Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Collagen alpha-1(XXVII) chain B;Collagen alpha-2(IV) chain;Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)"
"14"	6.68	"GO:0071711"	"basement membrane organization"	"A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the basement membrane."	"15.873% (10/63)"	6.106107e-05	4.21	"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g17199.t1"	"Hemicentin-1 (Fibulin-6) (FIBL-6);Tissue inhibitor of metalloproteinase;Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Hemicentin-1 (Fibulin-6) (FIBL-6);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha)"
"15"	8.76	"GO:0097104"	"postsynaptic membrane assembly"	"The aggregation, arrangement and bonding together of a set of components to form a postsynaptic membrane, a specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft)."	"37.5% (3/8)"	0.002110815	2.68	"Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1"	"Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)"
"15"	8.36	"GO:0097105"	"presynaptic membrane assembly"	"The aggregation, arrangement and bonding together of a set of components to form a presynaptic membrane, including any proteins associated with the membrane, but excluding other cellular components. A presynaptic membrane is a specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction."	"33.333% (5/15)"	0.00011671	3.93	"Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1"	"Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)"
"15"	7.7	"GO:0099054"	"presynapse assembly"	"The aggregation, arrangement and bonding together of a set of components to form a presynapse."	"33.333% (8/24)"	0.002968114	2.53	"Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1"	"Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Protein Wnt-7a;Frizzled-5 (Fz-5);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)"
"15"	6	"GO:1901888"	"regulation of cell junction assembly"	NA	"11.94% (16/134)"	0.002194072	2.66	"Pocillopora_acuta_HIv2___RNAseq.673_t;Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g614.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1"	"LHFPL tetraspan subfamily member 4 protein (Lipoma HMGIC fusion partner-like 4 protein);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Protein Wnt-7a;Roundabout homolog 2;Roundabout homolog 2;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3);Roundabout homolog 1;Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)"
"15"	7.57	"GO:0051965"	"positive regulation of synapse assembly"	"Any process that activates, maintains or increases the frequency, rate or extent of synapse assembly, the aggregation, arrangement and bonding together of a set of components to form a synapse."	"18.75% (6/32)"	0.0007519746	3.12	"Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1"	"Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Protein Wnt-7a;Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)"
"15"	8.67	"GO:0099151"	"regulation of postsynaptic density assembly"	"Any process that modulates the frequency, rate or extent of postsynaptic density assembly, the aggregation, arrangement and bonding together of a set of components to form a postsynaptic density."	"27.273% (3/11)"	0.005749353	2.24	"Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1"	"Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)"
"16"	8.87	"GO:0097067"	"cellular response to thyroid hormone stimulus"	"A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus."	"66.667% (6/9)"	1.383265e-07	6.86	"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1"	"Collagen alpha-2(I) chain (Alpha-2 type I collagen);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen)"
"16"	9.46	"GO:0071799"	"cellular response to prostaglandin D stimulus"	"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin D stimulus."	"60% (3/5)"	0.0004079179	3.39	"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1"	"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)"
"16"	8.58	"GO:0071305"	"cellular response to vitamin D"	"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus."	"25% (3/12)"	0.007468328	2.13	"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1"	"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)"
"16"	7.57	"GO:0071300"	"cellular response to retinoic acid"	"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus."	"24.242% (8/33)"	1.374758e-05	4.86	"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1"	"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen)"
"16"	7.93	"GO:0110096"	"cellular response to aldehyde"	"Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aldehyde stimulus."	"21.739% (5/23)"	0.001037266	2.98	"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1"	"Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen)"
"16"	8.36	"GO:0050922"	"negative regulation of chemotaxis"	"Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient."	"26.667% (4/15)"	0.001502552	2.82	"Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g9049.t1"	"Roundabout homolog 2;Roundabout homolog 2;Roundabout homolog 1;Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1)"
"16"	6.25	"GO:0071774"	"response to fibroblast growth factor"	"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fibroblast growth factor stimulus."	"10% (10/100)"	0.002626255	2.58	"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g6737.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b"	"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Protein Wnt-8a;ETS domain-containing protein Elk-1;Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)"
"16"	9.46	"GO:0071873"	"response to norepinephrine"	"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a norepinephrine stimulus. Norepinephrine is a catecholamine that has the formula C8H11NO3; it acts as a hormone, and as a neurotransmitter in most of the sympathetic nervous system."	"100% (5/5)"	5.203331e-08	7.28	"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1"	"Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen)"
"17"	8.29	"GO:0097150"	"neuronal stem cell population maintenance"	"Any process in by an organism or tissue maintains a population of neuronal stem cells."	"25% (4/16)"	0.001948436	2.71	"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g11002.t4"	"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]"
"17"	5.4	"GO:0001503"	"ossification"	"The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance."	"11.962% (25/209)"	0.006469638	2.19	"Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.g13857.t1;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g15163.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g19284.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g3780.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g23673.t1;Pocillopora_acuta_HIv2___TS.g28528.t1a;Pocillopora_acuta_HIv2___TS.g5338.t1"	"Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Bone morphogenetic protein 2 (BMP-2);Fibrillin-2 [Cleaved into: Placensin];Noggin-2;Collagen triple helix repeat-containing protein 1;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Protein kinase C-binding protein NELL1 (NEL-like protein 1);Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-1(XXVII) chain B;Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Signal peptide, CUB and EGF-like domain-containing protein 3;C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)"
"17"	6.74	"GO:0050817"	"coagulation"	"The process in which a fluid solution, or part of it, changes into a solid or semisolid mass."	"11.475% (7/61)"	0.005310079	2.27	"Pocillopora_acuta_HIv2___RNAseq.21015_t;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g22559.t1;Pocillopora_acuta_HIv2___RNAseq.g28195.t1;Pocillopora_acuta_HIv2___RNAseq.g30215.t1;Pocillopora_acuta_HIv2___RNAseq.g4785.t1;Pocillopora_acuta_HIv2___RNAseq.g4791.t1"	"Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain];Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain];Serine protease inhibitor dipetalogastin (Dipetalin);Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain];Coagulation factor VIII (Procoagulant component);Coagulation factor VIII (Procoagulant component)"
"17"	8.36	"GO:0097242"	"amyloid-beta clearance"	"The process in which amyloid-beta is removed from extracellular brain regions by mechanisms involving cell surface receptors."	"23.077% (3/13)"	0.009459176	2.02	"Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1"	"Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)"
"18"	6.89	"GO:0031644"	"regulation of nervous system process"	"Any process that modulates the frequency, rate or extent of a neurophysiological process, an organ system process carried out by any of the organs or tissues of the nervous system."	"12.963% (7/54)"	0.002656459	2.58	"Pocillopora_acuta_HIv2___RNAseq.g21967.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g7509.t2;Pocillopora_acuta_HIv2___RNAseq.g805.t1;Pocillopora_acuta_HIv2___RNAseq.g8670.t1;Pocillopora_acuta_HIv2___TS.g7062.t1"	"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)];Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Protein Wnt-7a;Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal];Protein turtle homolog B (Immunoglobulin superfamily member 9B);Riboflavin-binding protein (RBP) [Cleaved into: Riboflavin-binding protein, plasma form; Riboflavin-binding protein, yolk major form; Riboflavin-binding protein, yolk minor form];Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]"
"18"	9.27	"GO:1990708"	"conditioned place preference"	NA	"50% (3/6)"	0.0007945948	3.1	"Pocillopora_acuta_HIv2___RNAseq.g21562.t1;Pocillopora_acuta_HIv2___RNAseq.g9085.t1;Pocillopora_acuta_HIv2___TS.g23391.t1"	"CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)"
"18"	6.82	"GO:0007613"	"memory"	"The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task)."	"10.294% (7/68)"	0.009583178	2.02	"Pocillopora_acuta_HIv2___RNAseq.g14748.t1;Pocillopora_acuta_HIv2___RNAseq.g21562.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28252.t1;Pocillopora_acuta_HIv2___RNAseq.g9085.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g23391.t1"	"Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) (Calspermin);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)"
"19"	7.13	"GO:0032963"	"collagen metabolic process"	"The chemical reactions and pathways involving collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%)."	"23.529% (12/51)"	0.0005783218	3.24	"Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g19284.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g28528.t1a;Pocillopora_acuta_HIv2___TS.g5338.t1"	"Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)"
"19"	8.07	"GO:0030574"	"collagen catabolic process"	"The proteolytic chemical reactions and pathways resulting in the breakdown of collagen in the extracellular matrix, usually carried out by proteases secreted by nearby cells."	"30% (6/20)"	4.593423e-05	4.34	"Pocillopora_acuta_HIv2___RNAseq.g19284.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___TS.g28528.t1a;Pocillopora_acuta_HIv2___TS.g5338.t1"	"Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)"
"20"	8.43	"GO:0006030"	"chitin metabolic process"	"The chemical reactions and pathways involving chitin, a linear polysaccharide consisting of beta-(1->4)-linked N-acetyl-D-glucosamine residues."	"45.455% (5/11)"	0.003549458	2.45	"Pocillopora_acuta_HIv2___RNAseq.g12372.t1;Pocillopora_acuta_HIv2___RNAseq.g12376.t1;Pocillopora_acuta_HIv2___RNAseq.g25270.t1;Pocillopora_acuta_HIv2___RNAseq.g28575.t1a;Pocillopora_acuta_HIv2___RNAseq.g28577.t1"	"Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)"
"20"	8.99	"GO:0006032"	"chitin catabolic process"	"The chemical reactions and pathways resulting in the breakdown of chitin, a linear polysaccharide consisting of beta-(1->4)-linked N-acetyl-D-glucosamine residues."	"37.5% (3/8)"	0.002110815	2.68	"Pocillopora_acuta_HIv2___RNAseq.g12372.t1;Pocillopora_acuta_HIv2___RNAseq.g12376.t1;Pocillopora_acuta_HIv2___RNAseq.g25270.t1"	"Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41)"
"20"	7.6	"GO:0031638"	"zymogen activation"	"The proteolytic processing of an inactive enzyme to an active form."	"18.75% (6/32)"	0.0007519746	3.12	"Pocillopora_acuta_HIv2___RNAseq.21012_t;Pocillopora_acuta_HIv2___RNAseq.21015_t;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g30322.t1;Pocillopora_acuta_HIv2___RNAseq.g9381.t1"	"Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain];Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]"
"20"	9.27	"GO:0051045"	"negative regulation of membrane protein ectodomain proteolysis"	"Any process that stops, prevents, or reduces the frequency, rate or extent of membrane protein ectodomain proteolysis."	"50% (3/6)"	0.0007945948	3.1	"Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g30027.t1"	"Tissue inhibitor of metalloproteinase;Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4)"
"21"	7.51	"GO:0002456"	"T cell mediated immunity"	"Any process involved in the carrying out of an immune response by a T cell."	"20% (7/35)"	0.0001785733	3.75	"Pocillopora_acuta_HIv2___RNAseq.g21967.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g13017.t1;Pocillopora_acuta_HIv2___TS.g7062.t1"	"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)];Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Protein jagged-1 (Jagged1) (CD antigen CD339);Aryl hydrocarbon receptor (Ah receptor) (AhR);Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]"
"21"	7.43	"GO:0006956"	"complement activation"	"Any process involved in the activation of any of the steps of the complement cascade, which allows for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes; the initial steps of complement activation involve one of three pathways, the classical pathway, the alternative pathway, and the lectin pathway, all of which lead to the terminal complement pathway."	"27.586% (8/29)"	0.009118548	2.04	"Pocillopora_acuta_HIv2___RNAseq.21012_t;Pocillopora_acuta_HIv2___RNAseq.g30322.t1;Pocillopora_acuta_HIv2___RNAseq.g8820.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8922.t1;Pocillopora_acuta_HIv2___RNAseq.g9068.t1;Pocillopora_acuta_HIv2___RNAseq.g9084.t1;Pocillopora_acuta_HIv2___TS.g23144.t1"	"Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment];Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain];Complement factor B (EC 3.4.21.47) (C3/C5 convertase) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment];Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain]"
"21"	8.29	"GO:0006958"	"complement activation, classical pathway"	"Any process involved in the activation of any of the steps of the classical pathway of the complement cascade which allows for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes."	"31.25% (5/16)"	0.0001648993	3.78	"Pocillopora_acuta_HIv2___RNAseq.g8820.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8922.t1;Pocillopora_acuta_HIv2___RNAseq.g9084.t1;Pocillopora_acuta_HIv2___TS.g23144.t1"	"Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment];Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain];Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain]"
"22"	5.04	"GO:0009617"	"response to bacterium"	"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium."	"7.667% (23/300)"	0.0003611158	3.44	"Pocillopora_acuta_HIv2___RNAseq.10171_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g10378.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g19470.t1;Pocillopora_acuta_HIv2___RNAseq.g24413.t1;Pocillopora_acuta_HIv2___RNAseq.g26270.t1a;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g30726.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g8087.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g8820.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g9068.t1;Pocillopora_acuta_HIv2___RNAseq.g9084.t1;Pocillopora_acuta_HIv2___RNAseq.g9381.t1;Pocillopora_acuta_HIv2___TS.g13017.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g5618.t1"	"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin);Hemicentin-1 (Fibulin-6) (FIBL-6);Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206);Hemicentin-1 (Fibulin-6) (FIBL-6);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP);Toll-like receptor 2 (CD antigen CD282);Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5);Hemicentin-1 (Fibulin-6) (FIBL-6);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);NFX1-type zinc finger-containing protein 1;Hemicentin-1 (Fibulin-6) (FIBL-6);Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment];Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Complement factor B (EC 3.4.21.47) (C3/C5 convertase) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment];Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment];Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Aryl hydrocarbon receptor (Ah receptor) (AhR);Hemicentin-1 (Fibulin-6) (FIBL-6);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)"
"22"	9.27	"GO:0009608"	"response to symbiont"	"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a symbiont, an organism living with an organism of a different species in close physical association. The symbiont is defined as the smaller of the organisms involved in a symbiotic interaction."	"50% (3/6)"	0.0007945948	3.1	"Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g30726.t1;Pocillopora_acuta_HIv2___TS.g11002.t4"	"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]"
"23"	8.67	"GO:0006953"	"acute-phase response"	"An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals."	"27.273% (3/11)"	0.005749353	2.24	"Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g4785.t1;Pocillopora_acuta_HIv2___RNAseq.g4791.t1"	"Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Coagulation factor VIII (Procoagulant component);Coagulation factor VIII (Procoagulant component)"
"23"	9.27	"GO:0070654"	"sensory epithelium regeneration"	"The regrowth of a sensory epithelium following its loss or destruction."	"50% (3/6)"	0.0007945948	3.1	"Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1"	"Protein Wnt-8b;Protein Wnt-8b;Protein Wnt-8b"
"23"	7.7	"GO:0090303"	"positive regulation of wound healing"	"Any process that increases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury."	"21.429% (6/28)"	0.0003519511	3.45	"Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___TS.g5308.t2"	"SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)"
"23"	5.32	"GO:0009611"	"response to wounding"	"Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism."	"10.169% (24/236)"	0.003523586	2.45	"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.21015_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g22559.t1;Pocillopora_acuta_HIv2___RNAseq.g26270.t1a;Pocillopora_acuta_HIv2___RNAseq.g27031.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g28504.t1;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g30215.t1;Pocillopora_acuta_HIv2___RNAseq.g4785.t1;Pocillopora_acuta_HIv2___RNAseq.g4791.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g5308.t2"	"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain];SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain];Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1);Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2);Protein Wnt-7a;Matrilin-4 (MAT-4);Matrilin-2;Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain];Coagulation factor VIII (Procoagulant component);Coagulation factor VIII (Procoagulant component);Protein jagged-1 (Jagged1) (CD antigen CD339);Matrilin-2;Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)"
